Renal artery repair in African-Americans  by Deitch, Jonathan S. et al.
Renal artery repair in African-Americans 
Jonathan S. Deitch, MD, Kimberley J. Hansen, MD, 
T imothy E. Craven, MSPH,  John M. Flack, MD, MPH,  
Richard G. Appel, MD, and Richard H.  Dean, MD, Winston-Salem, N.C. 
Purpose: This retrospective review examines the results of atherosderotic renal artery 
(RA) repair in consecutive hypertensive African-Americans treated at out center and 
compares these results with Caucasians treated u_ring the same period. 
Methods: From Jan. 1987 through Sep. 1996, a total of 485 patients tmderwent operative 
RA repair. Of these, 28 African-Americans and 370 Caucasians were managed for 
atherosclerotic renovascular disease. These cohorts were compared on the basis of preop- 
erative blood pressure and renal function, extent of renal disease, extrarenal therosde- 
rosis, response to operation, and estimated survival. 
Results: The African-American cohort included nine men and 19 women (mean age, 62 
years) with hypertension (mean blood pressure, 204 4- 31/109 - 20 mm Hg) for an 
average of 10.2 + 7.5 years. Ischemic nephropathy (serum creaünine l vel, > 1.3 mg/dl) 
was present in 82% (n = 23) of the African-American group. RA reconstructions were 
unilateral in nine patients and bilateral in 19 patients (includlng repair to two solitary 
kidneys), for a total of 45 RA reconstructions (30 RA bypass procedures; eight transre- 
nal/transaortic RA endarterectomy procedures; two RA reimplantations; five nephrecto- 
mies). Nine patients underwent combined aortic procedures (four abdominal aortic 
aneurysm; five occlusive disease). There was one perioperative death in the African- 
American group as a result of sepsis and multiple organ failure. Among surgical survivors, 
20 African-American patients (74%) had a beneficial hypertension response (7% cured, 
67% improved). Mean estimated glomerular filtration rate improved significantly from 
34 to 42 ta l /min/ I .73 m 2 (p < 0.001). In the 23 patients with ischemic nephropathy, 13 
(57%) demonstrated greater than 20% decrease in serum creatinine l vel. In comparison 
with the 370 Caucasians (191 men, 179 women), the African-American cohort had 
significantly more preoperative heart dlsease (congestive heart failure or left ventricular 
hypertrophy; 68% vs 46%; p = 0.03) and tended toward more severe renal dysfunction 
(mean serum creafinine level, 2.5 vs 2.1 mg/dl; p = 0.25). However, African-Americans 
demonstrated a beneficial blood pressure and renal function response after operation, 
similar to Caucasians. 
Conclusions: Our results indicate that the majority of selected African-Americans have a 
favorable blood pressure and renal function response to operative renal artery repair. This 
beneficial clinical response appears equivalent to the response observed in Caucasian 
patients and supports the search for RA disease in hypertensive African-Americans. 
(J Vasc Surg 1997;26:465-73.) 
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Hypertension in African-Americans differs in a 
quantitative sense from that observed in Caucasians. 
Hypertension in African-American patients occurs 
with greater frequency and severity and at a younger 
age when compared with Caucasian patients. 1 In 
addition, elevated blood pressure at any level is asso- 
ciated with increased cardiovascular morbidity and 
renal disease in African-American patients. 2 Many 
putative mechanisms have been suggested to account 
for this aggressive form of hypertension that imply 
that hypertension i African-American patients is in- 
trinsically different from that in Caucasian patients. 3 
Although these mechanisms remain speculative, it
has generally been accepted that correctable r novas- 
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cular disease and renovascular hypertension (RVH) 
occur infrequently. 4-6Moreover, the increased end- 
organ damage at any level of hypertension along with 
the perceived low prevalence of RVH have limited 
enthusiasm for the investigation and treatment of 
renovascular disease in African-Americans. 
Conversely, race alone has not determined the 
evaluation or management of RVH at our center. In 
light of the conflicting opinions regarding RVH in 
African-Americans, we have made a retrospective r - 
view of our operative xperience with atherosclerotic 
renal artery disease in consecutive African-Americans 
to characterize preoperative blood pressure, renal 
function, extrarenat atherosclerosis, and prevalence 
of end-organ damage. These demographic features 
and the results of operative management were com- 
pared with those of 370 consecutive Caucasians 
treated uring the same period. Ethnic comparisons 
of specific interest included (1) the characteristics of
hypertension and extrarenal atherosclerosis associ- 
ated with renal artery disease; (2) the hypertension 
and renal function response to operative renovascular 
repair; and (3) the estimated survival rate after surgery. 
MATERIAL AND METHODS 
Patient population 
From January 1987 through September 1996, 
485 hypertensive patients underwent 498 operative 
procedures for repair of renovascular disease (RVD) 
at the Wake Forest University Medical Center, in- 
cluding 33 consecutive African-American patients. 
Twenty-eight adult African-Americans underwent 
repair of atherosclerotic renal artery disease and con- 
stitute the basis of this report. The atherosclerotic 
African-American group included nine men and 19 
women who ranged in age from 39 to 75 years 
(mean age, 62 years). All patients were hypertensive 
(mean blood pressure, 204 + 31/109 + 20 mm Hg; 
mean number of antihypertensive medications, 
2.6 + 0.9). The average duration of hypertension 
was 10.2 + 7.5 years before undergoing surgical 
revascularization. Ischemic nephropathy, defined as 
serum creatinine (SCr) level greater than 1.3 mg/dl, 
not taking diuretics, and converting enzyme inhibi- 
tors, was present in 23 patients (82%), including two 
dialysis-dependent pa ients. The mean SCr level for 
the African-American group was 2.5 + 1.7 mg/dl. 
The presence of extrarenal therosclerosis in the 
form of cardiac, cerebrovascular, andaortoiliac dis- 
ease was determined for all patients. Preoperative 
history of myocardial infarction was present in six 
African-American patients (21%), and congestive 
heart failure was evident by history or physical exam- 
ination in nine (32%). Left ventricular hypertrophy 
was present in 18 African-American patients (64%) 
on electrocardiogram or echocardiogram. Stroke or 
transient ischemic attacks were present in five pa- 
tients (18%), and two patients (7%) had undergone 
carotid endarterectomy. Significant aortoiliac occlu- 
sive disease was present in 21 of the African-Ameri- 
cans (75%), and aneurysmal disease was present in 
two (7%). Overall, 92% of patients demonstrated at 
least one manifestation f extrarenal therosclerosis. 
The demographic features and responses to opera- 
tion for these 28 African-Americans were compared 
with those of the 370 Caucasians who underwent 
operation for atherosclerotic RVD during the same 
period (Tables I and II). 
Patient management 
After a complete history, physical examination, 
and electrocardiogram, patients underwent addi- 
tional cardiac evaluation. The method and indication 
for cardiac assessment varied during the time period 
of this report. Cardiac evaluation i cluded resting or 
stress echocardiography (22 patients), exercise elec- 
trocardiography (five patients), and adenosine-thallium 
scintigraphy (seven patients). Coronary angiograms 
was obtained for five patients. Three African-Ameri- 
cans required coronary rtery revascularization pro- 
cedurcs before renal artery reconstruction. 
Renal duplex sonographic examination was used 
to identify patients who had RVD. A 60% or greater 
diameter-reducing stenosis or an occlusion of the 
main renal artery was considered a hemodynamically 
significant lesion. 7 All of the patients ubsequently 
underwent conventional cut-film angiography, 
which demonstrated bilateral disease in 17 patients 
(eight bilateral stenoses; one bilateral occlusion; 
eight bilateral stenosis/occlusions), unilateral dis- 
ease in nine patients (three unilateral stenosis; six 
unilateral occlusions), and disease that involved a 
solitary kidney in two patients (one stenosis; one 
occlusion). 
Tests of Amctional significance were performed 
in seven patients (seven renal vein renin assays 
[RVRAs]; one split renal function test). Lateraliza- 
tion of renin secretion was defined by a renal vein 
renin ratio of 1.5:1 or greater from the diseased 
kidney:normal lddney. Lateralization frenin activity 
or hyperconcentration of non-reabsorbable solute 
was observed in four of the seven patients tested. Of 
the 21 patients without preoperative functional tests, 
17 had bilateral RA disease, two had disease in a 
solitary kidney, and two had unilateral RA disease in 
conjunction with clinically significant aortic disease. 
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Table I. Comparison of African-Americans and Caucasians 
African-Americans Caucasians 
(n = 28) (n = 370) p 
Sex 
Male 9 (32%) 191 (52%) 0.05~ 
Female 19 (68%) 179 (48%) 
Age (yr _+ SD) 
Mean 62 + 8 63 + 10 0.47 t
Range (39 to 75) (30 to 86) 
Mean blood pressure (mm Hg) 204 + 31/109 _+ 20 198 +_ 37/103 _+ 22 0.47t* 
Duration hypertension (yr) 10.2 + 7.5 10.3 _+ 8.9 0.92 t
Diabetes (%) 18 16 0.79§ 
Cardiac (%) 
Angina/MI 32 43 0.26:~ 
CHF/LVH 68 46 0.03z~ 
Cerebrovascular (%) 
TIA/CVA 18 21 0.66~ 
CEA 7 14 0.40§ 
Renal 
Mean SCr level (mg/dl) 2.5 2.1 0.25 t 
Preoperative dialysis (%) 7 ó 0.69§ 
Aortic (%) 
AAA 7 7 1.00§ 
Occlusive 75 59 0.09:~ 
M/, Myocardial infarction; CHF, congestive heart failure; TIA, transient ischemic attack; CVA, cerebrovascular ccident; CEA, carotid 
endarterectomy; A_AA, abdominal aortic aneurysm; LVH, left ventricular hypertrophy. 
*p for systolic pressure only. 
}Unpaired t test. 
~X 2 test. 
§Fisher's exact est. 
Operative procedures 
Twenty-eight African-American patients under- 
weht 45 RA procedures. Nine underwent unilateral 
procedures, 17 underwent bilateral procedures, and 
two underwent repair of a solitary kidney. Operative 
procedures included 30 aortorenal bypass proce- 
dures (15 autologous aphenous vein, 15 polytetra- 
fluoroethylene), eight RA thromboendarterectomy 
procedures (six transrenal; two transaortic), two RA 
reimplantations, and five nephrectomies (two iso- 
lated, three contralateral procedures). Nephrectomy 
was performed only in cases where the distal renal 
artery was determined to be unreconstructible at the 
time of surgery, and this decision was not based on 
kidney size. 
Blood pressure response. Blood pressure and 
antihypertensive requirements 8 weeks after opera- 
tion were used to define the blood pressure response 
to operation. A patient was considered as cured if he 
or she had a diastolic blood pressure ofg0 mm Hg or 
less while receiving no antihypertensive medications. 
The patient was considered improved if the following 
criteria were met: (1) diastolic pressures were con- 
trolled less than 90 mm Hg before surgery, medica- 
tion requirements o achieve control taust have been 
reduced by at least two drugs; (2) for those patients 
Table II. Comparison of operative results 
between African-Americans and Caucasians 
African- 
American Caucasians 
(n = 28) (n = 370) 
Perioperative mortality rate (%) 3.6 3.7 1.0:~ 
Hypertension response (%)* 
Cured 7 11 0.19 t
Improved 63 74 
Unchanged 30 15 
Renal function response (%)* 
(Preoperative SCr -> 1.3) 
Improved 59 42 0.12 t
Unchanged 41 45 
Worsened 0 13 
*See text for definition. 
tx 2 test. 
~;Fisher's exact est. 
whose blood pressures were not controlled before 
surgery and who had a decrease in diastolic pressure 
of less than 20 mm Hg associated with postoperative 
control, medication requirements must have becn 
reduced by at least one drug; and (3) control of 
blood pressure with decrease in diastolic pressure of 
greater than 20 mm Hg on no more medication than 
before surgery. Patients who did not meet these 
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criteria for cured or improved were categorized as 
failed. 
Renal function response. A significant change 
in the excretory renal function after the operation 
was defined as a change greater than 20% in SCr level 
determined at least 3 weeks after surgery. Improved 
renal function was defined by a decrease in SCr level 
of at least 20% or removal from dialysis. Patients were 
determined to have worsened renal function if their 
SCr level increased by 20% or more. All others were 
considered unchanged. 
Statistical methods and analysis 
An analysis of the patients' renal function was 
performed using both SCr level (mg/dl) and SCr 
values transformed to estimated glomerulär filtration 
rates (EGFR; ta l /min / i .73  m2). EGFR was calcu- 
lated using the modified formula of Cockroft and 
Gault 8: 
EGFR = 
(140 - Age) (Weight) 
72 SCr 
1.73 
X 
BSA 
where body surface area (BSA) was calculated as 
BSA = (height [cm])  0"725 X (weight [kg])  0'425 X 
0.007184. For female patients, the EGFR was mul- 
tiplied by 0.85 to correct for gender differences in 
muscle mass and average rate of creatinine synthesis. 
Summary statistics (i.e., means, standard evia- 
tions ofcontinuous data, and frequeneies and relative 
frequencies of categorical data) were calculated, and 
the data were examined to verify that assumptions of 
statistical tests met. In African-American patients, 
analysis of differences in mean preoperative renal 
function (SCr level and EGFR) for patients having 
undergone unilateral versus bilateral repair was per- 
formed using unpaired t tests; analyses of postopera- 
tive changes in renal function for each group were 
performed using paired t tests; and analysis of differ- 
ences in mean postoperative r nal function between 
the two groups was performed using performed anal- 
ysis of covariance that controlled for preoperative 
functional levels. Comparison of categorical charac- 
teristics and graded blood pressure and hypertension 
responses to surgery between African-American and 
Caucasian patient groups were performed using X 2 
tests or Fisher's exact test for two-way contingency 
tables if any expected cell counts were less than live. 9 
Preoperative continuous characteristics of the two 
groups were compared using unpaired t tests. Signif- 
icance of within-patient changes in renal function 
was assessed using paired t tests. Differences between 
African-American and Caucasian patients in postop- 
erative renal function were examined using analysis 
of covariance that controlled for both preoperative 
function (i.e., preoperative l vels of SCr level or 
EGFR) and site of operation (unilateral or bilateral). 
Graphical depiction ofpostoperative survival data 
used product-limit estimates of the survival disttibu- 
tions for African-Americans and Caucasians. Signifi- 
cance of differences in survival distributions between 
the two groups was assessed using the log-rank 
test. ] °  
RESULTS 
No significant difference was observed for severity 
or duration of hypertension between the African- 
American and Caucasian groups. Of note, the African- 
American group had a significantly greater proportion 
of women (p = 0.05). Overall, African-Americans 
had a greater prevalence of clinically detectable car- 
diovascular disease. African-Americans demonstrated 
a significantly greater prevalence of left ventricular 
hypertrophy compared with Caucasians (p = 0.02). 
Left ventricular hypertrophy was present in 18 Afri- 
can-American patients (64%) by electrocardiographic 
and echocardiographic criteria compared with the 
42% in the Caucasian cohort. Clinical congestive 
heart failure and significant aortoiliac occlusive dis- 
ease were more common in Aftican-Americans but 
did not differ significantly from Caucasians (p = 
0.09). More extensive RA disease was noted among 
African-Americans compared with Caucasians. Bilat- 
eral RVD was present in 68% of African-Americans 
compared with 54% of Caucasians (p = 0.16). More- 
over, African-American patients tended toward 
more severe excretory renal dysfunction (mean 
SCr level, 2.5 vs 2.1 mg/dl ;  p = 0.25). Fifty-seven 
percent of African-Americans, compared with 40% 
of Caucasians, were determined to have severe 
renal dysfunction (SCr level greater than 2.0 mg/  
dl; p = 0.07). 
Operative morbidity and mortality data 
Early events. Early events were defined as those 
that occurred within 30 days of the surgical proce- 
dure. There was one in-hospital death as a result of 
sepsis and multiple organ system failure after the 
patient underwent unilateral transrenal endarterec- 
tomy with contralateral nephrectomy. Serious peri- 
operative morbidity prolonging hospitalization i - 
cluded one patient who required an above-knee 
amputation i the early postoperative p riod. In ad- 
dition, one case of pneumonia requiring prolonged 
ventilatory support, one complex arrhythmia, and 
one wound infection occurred. Orte patient required 
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Fig. 1. Product-limit estimate of time to death for MYican-Americans (solid line) compared 
with Caucasians (broken line) treated during the same period. 
a transient period of hemodialysis within the first 
postoperative month. 
Late events. One late death occurred in a dialy- 
sis-dependent patient who was initially removed 
from dialysis after bilateral renal artery bypass graft- 
ing. Two months after surgery, this patient's renal 
artery bypass grafts thrombosed and necessitated bi-
lateral RA thrombectomy. He died of sepsis and 
multisystem organ failure 4 months after undergoing 
his second operation. Two patients experienced sig- 
nificant morbidity, which included a cerebrovascular 
accident and progression to dialysis dependence d - 
spite a patent unilateral renal artery bypass graft by 
duplex sonography, 
Fig. 1 illustrates the product-limit estimate of 
time to death for African-Americans compared with 
Caucasians treated uring the same period. The me- 
dian follow-up was not significantly different for the 
African-American (8.7 months) and Caucasian ( 10.5 
months) cohort (Wilcoxon two-sample test; p = 
0.92). Survival among African-Americans and Cau- 
casians was not influenced by the blood pressure 
response to surgery. In contrast o the Caucasian 
cohort, improved renal function after operation in 
African-Americans was not associated with improved 
estimated survival rate. 
Surgica l  outcome 
Eight weeks after operation, two patients were 
considered cured, 18 patients were improved, and 
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Table II I .  Blood pressure response to operation (n = 27) in African-Americans 
Preoperative 
No. of Mean blood 
patients pressure No. of 
Response (%) (mm Hg) +- SD) medications + SD 
Postoperative 
Mean blood 
pressure No. of 
(mm Hg) +- SD medications + SD 
Cured 2 (7.4%) 195 ± 7 /115  -+ 35 2.5 ± 0.7 
Improved 18 (66.6%) 202 ± 29 /109  +- 109 2.7 _+ 0.9 
Failed 7 (26%) 214 ± 39/109 ± 18 2.4 +_ 0.8 
128 ± 14/79 +- 7 0 
152 -+ 24 /84  -- 17 1.9 ± 0.8 
175 ± 32/98 ± 15 2.4 ± 1.1 
Table IV. Renal function response to  
operation in African-Americans versus 
preoperative SCr level (n = 27) 
SCr < 1.3 SCr »- 1.3 to 2.0 SCr > 2.0* 
Improved 0 1 12 
Unchanged 4 7 3 
Worsened 0 0 0 
*Includes two dialysis-dependent patients (one patient removed 
from dialysis dependence). 
seven patients had a failed blood pressure response; 
however, even among patients in the failed group the 
mean systolic blood pressure after surgery averaged 
40 mm Hg lower than the preoperative l vel. Con- 
sidering the operative death as a failed blood pressure 
response, two patients (7%) were cured, 18 (64%) 
improved, and eight (29%) failed. Blood pressure 
response to renal revascularization was not influ- 
enced by patient age, sex, or duration of hyperten- 
sion. Table III summarizes the change in mean 
blood pressure and medications after surgery in Afri- 
can-Americans. Of the five patients who underwent 
nephrectomy for unreconstructible disease, the 
blood pressure response was improved in four and 
failed in one. 
Among seven patients with RVRAs, two of four 
with lateralizing studies had an improved blood pres- 
sure response to surgery, whereas two patients were 
considered failed. Of the 26 patients with either 
nonlateralizing or no RVRAs performed, two were 
cured, 19 were improved, and five had a failed blood 
pressure response. 
Among operative survivors with ischemic ne- 
phropathy (SCr level greater than 1.3 mg/dl) ,  13 
patients (57%) were considered improved, including 
one patient who was removed from dialysis, whereas 
20 (43%) were considered unchanged. No patient's 
SCr level worsened. Improvement in renal function 
was not influenced by the severity of preoperative 
renal dysfunction (Table IV). Considering all Afri- 
can-Americans, there was a significant decrease in 
mean SCr level (2.5 vs 1.8 mg/dl ;  p = 0.002) and a 
Table V. Change in EGFR versus ite of 
operation (n = 27) in African-Americans 
No. of 
patients 
Unilateral 8 
Preoperative Postoperative 
EGFR EGFR 
(mean + SE) (mean ++- SE)* 
Bilateral 19 
37.6 _+ 7.1 4--p = 0.004--->42.5 ± 3.2 
p = 0.55§ p = 0.90t 
32.5 + 4.5 <--p = 0.004--+42.0 + 2.1 
*Postoperative EGFR and test for differences estimated after con- 
trolling for preoperative EGFR levels. 
tAnalysis of covariance. 
z~Paired t test. 
§Unpaired t test. 
significant increase in EGFR (34 vs 42 ml /min / l .73  
m2; p = 0.0002). Both unilateral and bilateral repair 
were associated with significant renal function im- 
provement in African-American patients (p < 0.01). 
Overall, of the 27 surgical survivors, 24 (85%) dem- 
onstrated either an improved blood pressure or renal 
function response to renal artery surgery. Table V 
compares preoperative and postoperative excretory 
renal functäon according to site of operation, con- 
trolling for preoperative EGFR levels for the 27 sur- 
gical survivors. 
Despite the tendency toward greater prevalence 
of cardiovascular disease, increased extent of renal 
disease, and more severe renal dysfunction, the blood 
pressure response was equivalent for African-Ameri- 
cans and Caucasians. Although the proportion of 
patients with improved renal function after surgery 
did not differ significantly, African-Americans dem- 
onstrated a greater decline in SCr level compared 
with the Caucasian cohort (0.74 mg/dl  vs 0.14 
mg/dl  decrease; p < 0.05). Unlike the Caucasian 
cohort, equivalent and significant improvement was 
observed in African-Americans regardless of the site 
of disease or extent of operation. Significant im- 
provement in renal function among Caucasians was 
observed only for bilateral RA repairs. Hypertension 
and renal function response for both cohorts are 
summarized in Table 12. 
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DISCUSSION 
Compared with essential hypertension i Cauca- 
sians, hypertension i African-Americans is approxi- 
mately 40% more prevalent, tends to occur at an 
earlier age, is usually more severe within any age 
range, and is associated with a greater frequency of 
pressure-related nd-organ damage. 1 For any given 
elevation in blood pressnre, African-Americans dem- 
onstrate an increased mortality rate as a result of 
hypertensive heart disease, stroke, and renal dis- 
ease.2,11 Considered in context of the genetic, physi- 
ologic, and socioeconomic explanations oßEred for 
these ethnic differences, hypertension and its associ- 
ated morbidity are often considered inevitable in 
African-American patients.12 
For many, this discouraging view also applies to 
RVH in African-Americans. Data derived from 7200 
African-American adults referred to a tertiary hyper- 
tension clinic demonstrated that RVH was present in 
only 0.2%. la A low prevalence for RVH among hy- 
pertensive African-Americans was also suggested by 
the Cooperative Study of Renovascular Hyperten- 
sion. 14 Although African-Americans comprised 30% 
of the study sample, only 8% of the patients with 
renal artery stenosis were African-American. Foster et 
al. 6 described a lower prevalence of renal artery ste- 
nosis in African-American women compared with 
Caucasian women. Moreover, no case of advanced 
renovascular disease was found in M>ican-American 
men compared with a 30% prevalence in Caucasian 
men. 6 Given the apparent rarity of renovascular dis- 
ease and RVH, these authors uggested that hyper- 
tensive African-Aanericans should not be subjected to 
extensive investigation for renal arte W disease. 
By contrast, we believe that the presence of ath- 
erosclerotic renovascular disease is not determined 
by a patient's ethnicity. Preliminary results from an 
ongoing population-based study at our center sug- 
gest that African-American patients and Caucasian 
patients demonstrate equivalent prevalences of he- 
modynamically-significant re ovascular disease. A1- 
though renal artery disease may occur with equal 
frequency, this is not to say that RVH contributes 
equally to hypertension i  African-American patients 
and Caucasian patients. In this regard, we reviewed 
the results from renal duplex studies obtained to 
screen for renovascular disease among hypertensive 
patients with and without excretory renal insuffi- 
ciency (Table VI). From July 1995 through June 
1996, 629 consecutive subjects, including 127 Afri- 
can-Americans (20%) and 502 Caucasians patients 
(80%), were screened at our center (unpublished 
data). Twelve percent of African-Americans and 28% 
Table VI. Comparison of renal duplex 
sonography in 629 hypertensive subjects 
Positive Negative 
RDS* (%) RDS (%) Total (%) 
M}ican-Amcricans 15 (11.8) 112 (88.2) 127 (20) 
Caucasians 139 (27.5) 363 (72.5) 502 (80) 
Totalpatients screened 154 (24.4) 475 (75.6) 629 (100) 
p <~ 0.001, X 2. 
*Positive RDS: -> 60% diameter reducing stenosis or occlusion on 
renal duplcx sonography. 
of Caucasian subjects demonstrated renovascular dis- 
ease by duplex criteria (p < 0.001). 7 This highly 
significant difference between African-Americans and 
Caucasians hould be considered in context of the 
selection criteria for study. The primary clinical crite- 
ria that prompted renal duplex examination for the 
entire group was severe or ditficult-to-control hyper- 
tension. Because severe hypertension occurs more 
commonly in African-American patients compared 
with Caucasian patients, proportionately fewer Afri- 
can-Americans would be expected to demonstrate 
renovascular disease when screened by these selec- 
tion criteria. 
Similar prevalence estimates for renovascular dis- 
ease among hypertensive At¥ican-Americans have 
been reported by Svetkey et al. is Based on selection 
criteria that emphasized severe and accelerated hy- 
pertension, 67 African-American and 97 Caucasian 
subjects were screened for renal artery disease by 
conventional angiography. Among these subjects, 
19% of African-Americans and 27% of Caucasians 
demonstrated hemodynamically significant renovas- 
cular disease. Each patient with disease had renal 
artery intervention by either percutaneous balloon 
angioplasty or surgery. Among African-Americans, 
9% of subjects creened had a beneficial blood pres- 
sure response after intervention confirming the pres- 
ence of RVH. 
Based on our findings, we believe that clinicians 
should search for a renovascular cause of severe hy- 
pertension without regard to race. Although propor- 
tionately fewer African-American patients will dem- 
onstrate RVH compared with Caucasians, the 
beneficial effects of operative renovascular repair are 
demonstrated by our reported experience. Despite 
more prevalent cardiovascular disease, the blood 
pressure benefit was equivalent for African-Ameri- 
cans and Caucasians. Especially gratifying was the 
observed improvement in excretory renal function in 
the African-American cohort. Both unilateral and 
bilateral renal reconstruction were associated with 
significantly improved renal function, which in turn 
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was significantly greater than the  improvement ob- 
served in the Caucasian cohort. Although no rela- 
tionship between renal function response and estimated 
survival was demonstrated for African-American pa- 
tients, we suspect his reflects out small patient hUre- 
ber. When the entire group of  patients with athero- 
sclerotic renal artery disease are considered, 
improved excretory renal function after operation is a 
significant and independent predictor o f  improved 
estimated survival. 16 This relationship between renal 
function response and survival has also been ob- 
served for subgroups of  elderly patients (i.e., >60 
years o f  age) and patients with diabetes. :7,18 We 
suspect hat a similar relationship will be observed for 
African-Americans when a greater number  o f  pa- 
tients are available for follow-up. 
Lastly, the importance of  peripheral or selective 
renin determinations among African-Americans i
controversial. Previous studies have suggested a lim- 
ited role for RVRA in the evaluation of  RVH. :3 A 
lower peripheral plasma renin activity in hypertensive 
African-Americans and a low Captopril-stimulated 
peripheral renin level in African-Americans with 
RVH add to the uncertainty o f  renin determination 
in African-Americans) s In this regard, an equivalent 
blood pressure response to surgery was observed in 
African-American patients with lateralizing RVRAs, 
compared with patients who did not lateralize or had 
no preoperative RVRA determined. Although our 
numbers are too few to mal:e a conclusive statement 
regarding renin determination i African-Americans, 
we believe this is an important area for future study. 
CONCLUSION 
African-Americans with hypertension are infre- 
quently evaluated for atherosclerotic renovascular 
disease. In part, this practice may reflect the belief 
that renal artery disease is rare in African-Americans 
and, when present, exists in combination with end- 
organ damage limiting the success o f  intervention. 
Although fewer African-Americans with severe or 
difficult-to-control hypertension will demonstrate 
renovascular disease compared with Cancasians, we 
believe that RVH is present in a significant propor- 
tion o f  hypertensive African-Americans. Although 
limited by our small sample size, we did not find any 
difference in the beneficial blood pressure or renal 
function response between African-Americans an 
Caucasians, thus supporting the search for RVH in 
African-Americans. 
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DISCUSSION 
Dr. Charles S. O'Mara (Jackson, Miss. ). The Bow- 
man-Gray group has once again provided us with impor- 
tant information about renal artery occlusive disease with 
this evaluation of racial influences. Even though hyperten- 
sion is clearly a worse villain in African-Americans than in 
Cancasians, it is reassuilng to hear that standard selection 
criteria re useful in identifying African-Americans who will 
benefit from renal revascularization procedures. Our group 
has also held the believe that race alone should not mitigate 
against revascularization i  selected African-Americans 
with renovascular hypertension. Among 290 renal revascu- 
larization procedures over the past 14 years in our practice, 
17 patients were African-Ameilcan, about 6%, almost iden- 
tical to the percentage of blacks in the Bowman-Gray 
study. Our seiles shows some minor differences, uch as an 
older average age of 72 years, but our data basically mir- 
rored the data presented here. Our African-Ameilcan pa- 
tients similarly had a female predominance of 59% in con- 
trast o strong male predominance of64% in our Cancasian 
patients. Bilateral reconstructions were performed in fewer 
than one third ofour operations, but extrarenal theroscle- 
rosis was evident in all but two of our 17 patients. We 
fortunately had no perioperative d aths. Our rate of bene- 
ficial blood pressure response was 82%. Improved renal 
function by the Bowman-Gray cilteria was achieved in one 
half of our eight patients who had ischemic nephropathy 
before surgery. The äverage serum creatinine level among 
patients with ischemic nephropathy improved from 2.2 
mg/d l  before operation to 1.7 mg/d l  after operation. Like 
the Bowman-Gray study, results of hypertension and renal 
functional response varied litfle between our Afilcan- 
American and Cäucasian patients. In brief, our results co- 
incided with the data presented this morning. We therefore 
agree with the importance of searching for a renovascular 
cause of severe hypcrtension without regard to race, and 
we also believe that a beneficial blood pressure response 
and renal functional response can be achieved in selected 
African-American patients. 
I have several questions. First, what do the authors 
think accounts for the predominance of women among 
African-Americans with atherosclerotic renal artery dis- 
ease? Regarding operative technique, what are the princi- 
ple determinants in deciding between endarterectomy and 
bypass grafting, and what graft material do you favor when 
performing bypass procedures? Given the apparent exten- 
sive nature of atherosclerotic disease in black patients, is 
race a consideration with regard to operative technique? 
Dr. Jonathan S. Deitch. Thank you for your kind 
comments. We also found a slight female predominance in 
our African-American cohort sirnilar to your study. The 
reasons for this were unclear. In answer to your second 
question, we usually reserve endarterectomy for bilateral 
disease and for patients who have accessory renal arteries. 
Otherwise, our primary operative procedure would be aor- 
torenal bypass grafting, which we performed in 30 of ohr 
patients. We did not base consideration of operative tech- 
niques on race. We evaluated each patient individually and 
performed the operation dictated by the patient's anatomy. 
In answer to the question regarding raft choice, we prefer 
to use saphenous rein when that option is available and 
when vein is not limited from pilor operative procedures. 
Our standard for using vein is t)lat they have a diameter 
greater than or equal to 4 mm. Otherwise, we typically use 
polytetrafluoroethylene. 
Dr. El l iot L. Chaikof (Atlanta, Ga.). I enjoyed your 
presentation. What proportion of these patients had func- 
tional studies that documented renovascular hypertension, 
and what are your current indications for using those 
studies? 
Dr. Deitch. We performed functional studies in seven 
of our patients. Typically, we will use functional studies in 
patients who have unilateral disease. Patients with bilateral 
disease or disease loeated to an isolated kidney will not 
undergo functional studies. 
Dr. Francis Robicsek (Charlotte, N.C.). From this 
very interesting paper and also from the primary discus- 
sion, somebody may ger the impression that you are facing 
an andience that has a practice of using different standards 
in renovascular hypertension for African-American patients 
and Caucasian patients. I have absotutely no knowledge 
that anybody does. So, to me, the results are reassuilng, 
but certainly I don't believe I needed any convincing. My 
question is, in our practice about 90% to 95% of the 
patients are not treated by surgery but with stent insertion. 
This practice developed in the last 5 years. I wonder what 
our neighbors at Winston-Salem are doing? Do you do any 
at all or did you not include that in this study, and if not, 
why? 
Dr. Deitch. None of the patients in this Afilcan- 
Ameilcan cohort that we studied underwent steht place- 
ment. In general, we do not advocate stenting osteolesions 
and reserve stents for patients who have atherosclerotic 
lesions involving the main renal artery. Some patients who 
are referred to us have received stents at other centers. 
